DPHA — Disruptive Pharma AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK21.98m
- -SEK12.12m
Brief: Guard Therapeutics Q3 Pretax Loss Narrows To SEK 8.0 Mln
Brief: Guard Therapeutics Presents Pre-Clinical Results For ROSgard
Brief: A1m Pharma: Positive Top-Line Results From Phase 1A Study Of ROSgard
Brief: A1M Pharma Q2 Pretax Loss Narrows To SEK 11.0 Million
Brief: A1M Pharma Gets Information About Future Patent Approval In US
Brief: A1M Pharma Appoints Torun Labedzki As New CFO
Brief: A1M Pharma Carries Out Private Placement Of About SEK 27.2 Mln
Brief: A1M Pharma CFO Gunnar Telhammar Resigns
Brief: A1M Pharma Board Chairman Declines Re-election
Brief: A1M Pharma Q1 Pretax Loss SEK 13.9 Million
Brief: A1M Pharma Q4 Pre-Tax Loss Widens To SEK 40.2 Mln
Brief: A1m Pharma Gets About SEK 70.5 Million Before Issue Costs
Brief: A1M Pharma Proposes Rights Issue Of SEK 70.5 Million
Brief: A1M Pharma Changes CEO And Reduces Costs
Brief: A1M Pharma Elects Anders Ermén New Chairman
Brief: A1M Pharma Gets Information Of Coming Approval Of Patent In USA
Brief: A1M Pharma Receives Observation Status On Nasdaq First North
Brief: A1M Pharma Q3 Pre-Tax Loss Narrows To SEK 16.6 Million
Brief: A1M Pharma Re-Submits Application To Conduct Clinical Trial With Rosgard